The Titbits of Multi-drug Resistant Organisms Reigning in the Diabetic Foot Ulcers: Regional Epidemiology From a Tertiary Care Hospital of Eastern India

Document Type : Original Article

Authors

1 Department of Microbiology, Calcutta National Medical College and Hospital, Kolkata, The West Bengal university of Health Sciences, West Bengal, India

2 Department of Pathology, Calcutta National Medical College and Hospital, Kolkata, The West Bengal university of Health Sciences, West Bengal, India

Abstract

Background and aim: One of the worst complications of diabetes mellitus is diabetic foot infections (DFI). A varied presentation is reported for both the causative bacterial species and their drug resistance patterns. We intended to evaluate the prevalence of drug-resistant strains among aerobic bacterial profile of DFI -as there was no regional data available to implement a rational antibiotic therapy for better management.
Materials and methods: This cross-sectional observational study included 102 DFI cases attending this hospital with Wagner grade-1 or above ulcers. Wound swabs were taken from the base of the ulcers after a thorough cleaning. They were inoculated in blood agar, and MacConkey agar and drug sensitivity were performed Kirby Bauer disc diffusion method following the guidelines by the Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing standards.
Results: Altogether, 135 bacterial isolates were reported with an average of 1.32 bacteria per ulcer with Gram-negative bacilli in 63.7% and Gram-positive cocci in 36.3% cases. However, when individual isolates were considered, Staphylococcus aureus was the commonest species, followed by Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii complex, and Pseudomonas aeruginosa. Drug resistance was rampant, with 69.1% multi-drug resistant organisms (MDRO) among them. Methicillin-resistant Staphylococcus aureus (MRSA) was 81.3%, MRCONS 66.7%, and extended-spectrum β-lactamase (ESBL)- producer Gram-negative Bacteria (GNB) 47.3%.
Conclusion: In this scenario, Vancomycin and linezolid were the only effective drugs against GPC. Piperacillin-tazobactam and imipenem were effective for GNB in general except ESBL or Metallo-beta-lactamase (MBL) producing Acinetobacter and Pseudomonas species, which showed a dangerous inclination for treatment failure.

Keywords

Main Subjects


[1]  Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-40. doi:10.1001/jama.2009.726.
[2]  Cunha BA. Antibiotic selection for diabetic foot infections: a review. The Journal of foot and ankle surgery. 2000;39(4):253-7. https://doi.org/10.1016/S1067-2516(00)80009-5.
[3] Richard JL, Sotto A, Lavigne JP. New insights in diabetic foot infection. World jour-nal of diabetes. 2011;2(2):24. doi: 10.4239/wjd.v2.i2.24.
[4]  Kandemir Ö, Akbay E, Şahin E, Milcan A, Gen R. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. Journal of Infection. 2007;54(5):439-45. https://doi.org/10.1016/j.jinf.2006.08.013.
[5]  Ako-Nai AK, Ikem IC, Akinloye OO, Aboderin AO, Ikem RT, Kassim OO. Character-ization of bacterial isolates from diabetic foot infections in Ile-Ife, Southwestern Ni-geria. The Foot. 2006;16(3):158-64. https://doi.org/10.1016/j.foot.2006.05.001.
[6]  Akhi MT, Ghotaslou R, Asgharzadeh M, Varshochi M, Pirzadeh T, Memar MY, et al. Bacterial etiology and antibiotic susceptibility pat-tern of diabetic foot infections in Tabriz, Iran. GMS hygiene and infection control. 2015;10. doi: 10.3205/dgkh000245.
[7]  Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. Journal of clinical Microbiology. 2007;45(9):2819-28. DOI: 10.1128/JCM.00551-07.
[8]  González FC, Alramadan M, Matesanz M, Diaz A, Gonzalez-Romo F, Candel I, et al. Infections in diabetic foot ulcers. European journal of internal medi-cine. 2003;14(5):341-3. https://doi.org/10.1016/S0953-6205(03)00107-9.
[9]  Altclas J, Jasovich A, Mikaelian G, Fiks G, Caro E. Microbiology and conservative surgery of serious infections of the diabetic foot. Enfermedades infecciosas y micro-biologia clinica. 1992;10(8):451-5.
[10] MacDonald YG, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabetic Medicine. 2002;19(12):1032-4. https://doi.org/10.1046/j.1464-5491.2002.00696_1.x.
[11] Clinical and Laboratory standards institute (CLSI). Performance standards for anti-microbial susceptibility testing. 30th Ed.CLSI supplement M100. 2020;40(1).Wayne,PA.
[12] Zubair M, Malik A, Ahmad J. Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India. Biol Med. 2010;2(4):22-34.
[13] Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and wi-thout peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747-55. https://doi.org/10.1007/s00125-008-0940-0.
[14] Otta S, Debata NK, Swain B. Bacteriological profile of diabetic foot ulcers. CHRISMED Journal of Health and Research. 2019;6(1):7-11. DOI: 10.4103/cjhr.cjhr_117_17.
[15] Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. Journal of microbiology immunology and infec-tion. 2007;40(1):39-44.
[16] Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian journal of pathology & microbiology. 2002;45(1):15-22.
[17] Louie Tj, Bartlett Jg, Tally Fp, Gorbach Sl. Aerobic and anaerobic bac-teria in diabetic foot ulcers. Annals of internal medicine. 1976;85(4):461-3. https://doi.org/10.7326/0003-4819-85-4-461.
[18] Sapico FL, Canawati HN, Witte JL, Montgomerie JZ, Wagner FW, Bessman AN. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. Journal of Clinical Microbiology. 1980;12(3):413-20.
[19] Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of dia-betic foot infections. Journal of diabetes and its complications. 2005;19(3):138-41. https://doi.org/10.1016/j.jdiacomp.2004.06.001.
[20] Suresh A, Muthu G, Srivani R, Moses A. Aerobic bacterial resistance in diabetic foot ulcer from Chennai. International Journal of Pharma and Bio Sciences. 2011;2(2):517-28.
[21] Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes care. 2006;29(8):1727-32. https://doi.org/10.2337/dc06-0116.
[22] Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, et al. Microbiological study of diabetic foot infections. Indian journal of medi-cal specialities. 2011;2(1):12-17.
[23] Mohanasoundaram KM. The microbiological profile of diabetic foot infec-tions. Journal of Clinical and Diagnostic Research. 2012;6(3):409-11.
[24] Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin‐resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabetic Medicine. 2003;20(2):159-61. https://doi.org/10.1046/j.1464-5491.2003.00860.x.
[25] Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR. Bacterial etiology of diabetic foot infections in South India. European journal of internal medicine. 2005;16(8):567-70. https://doi.org/10.1016/j.ejim.2005.06.016.
[26] Manisha J, Mitesh P, Nidhi S, Dhara M, Vegad M. Spectrum of microbial flora in di-abetic foot ulcer and its antibiotic sensitivity pattern in tertiary care hospital in Ah-medabad, Gujarat. Nat J Med Res. 2012;2(3):354-7.
[27] Shobha KL, Ramachandra L, Rao G, Majumder S, Rao SP. Extended spectrum beta-Lactamases (ESBL) in gram negative bacilli at a tertiary care hospital. J Clin Diagn Res. 2009;3:1307-2.
[28] Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact. Diabetic Medicine. 2004;21(7):710-5. https://doi.org/10.1111/j.1464-5491.2004.01237.x.
Volume 3, Issue 1
March 2021
Pages 6-11
  • Receive Date: 13 December 2020
  • Revise Date: 25 January 2021
  • Accept Date: 01 February 2021
  • First Publish Date: 05 February 2021